![]()  | |
| Clinical data | |
|---|---|
| Trade names | Clotam, Clotan, Tufnil | 
| AHFS/Drugs.com | International Drug Names | 
| Routes of administration  | By mouth | 
| ATC code | |
| Legal status | |
| Legal status | 
  | 
| Identifiers | |
  | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | 
  | 
| UNII | |
| KEGG | 
  | 
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.033.862 | 
| Chemical and physical data | |
| Formula | C14H12ClNO2 | 
| Molar mass | 261.71 g·mol−1 | 
| 3D model (JSmol) | |
  | |
  | |
|   | |
Tolfenamic acid (Clotam, Tufnil) is a member of the anthranilic acid derivatives (or fenamate) class of NSAID drugs discovered by scientists at Medica Pharmaceutical Company in Finland.[2] Like other members of the class, it is a COX inhibitor and prevents formation of prostaglandins.[3]
It is used in the UK as a treatment for migraine.[4] It is generally not available in the US.[3] It is available in some Asian, Latin American and European countries as a generic drug for humans and for animals.[5]
References
- ↑ Andersen KV, Larsen S, Alhede B, Gelting N, Buchardt O (1989). "Characterization of two polymorphic forms of tolfenamic acid, N-(2-methyl-3-chlorophenyl)anthranilic acid: their crystal structures and relative stabilities". J. Chem. Soc., Perkin Trans. 2 (10): 1443–1447. doi:10.1039/P29890001443.
 - ↑ Pentikäinen PJ, Neuvonen PJ, Backman C (1981). "Human pharmacokinetics of tolfenamic acid, a new anti-inflammatory agent". European Journal of Clinical Pharmacology. 19 (5): 359–65. doi:10.1007/bf00544587. PMID 7238564. S2CID 9428076.
 - 1 2 NIH LiverTox Database Mefenamic Acid Last updated June 23, 2015. Page accessed July 3, 2015. Quote: "(fenamates generally not available in the United States, such as tolfenamic acid and flufenamic acid)"
 - ↑ NHS Tolfenamic Acid (Tolfenamic acid 200mg tablets) Page accessed July 3, 2015
 - ↑ Drugs.com Drugs.com international listings for tolfenamic acid Page accessed July 3, 2015
 
External links
- Tolfenamic acid information (Diseases Database)
 
| pyrazolones / pyrazolidines  | |
|---|---|
| salicylates | |
| acetic acid derivatives and related substances  | |
| oxicams | 
  | 
| propionic acid derivatives (profens)  | 
  | 
| n-arylanthranilic acids (fenamates)  | |
| COX-2 inhibitors (coxibs)  | |
| other | |
| NSAID combinations  | |
Key: underline indicates initially developed first-in-class compound of specific group; #WHO-Essential Medicines; †withdrawn drugs; ‡veterinary use.  | |
| Receptor (ligands)  | 
  | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Enzyme (inhibitors)  | |||||||||||||||||
| Others | |||||||||||||||||
  | |||||||||||||||||
| Calcium | 
  | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Potassium | 
  | ||||||||||||||||||||||||
| Sodium | 
  | ||||||||||||||||||||||||
| Chloride | 
  | ||||||||||||||||||||||||
| Others | 
  | ||||||||||||||||||||||||
See also: Receptor/signaling modulators • Transient receptor potential channel modulators  | |||||||||||||||||||||||||
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
